Bruggen lab @ University of Zurich
Bruggen lab @ University of Zurich
People
Projects
Publications
News
Contact
3
Predicting Dupilumab Treatment Outcome in Patients with Primary diffuse Type 2 Chronic Rhinosinusitis.
Soyka M, Ryser F, Brühlmann C, Schmid-Grendelmeier P, Fehr D, Brüggen MC, Steiner U
PDF
Vitiligo-like depigmentation in patients treated with checkpoint inhibitors: Clinical characteristics and predictive proteomic patterns.
Hermann N, Maul LV, Traidl S, Ameri M, Ziadlou R, Kolm-Djamei I, Levesque M, Maul JT, Brüggen MC*
PDF
Cite
×